Medical and Pharmaceutical Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug 'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients Rowan DunneJanuary 17, 2025
Medical and Pharmaceutical Baird Medical rubs shoulders with investors at prestigious healthcare event, sees 77% spike The annual J.P. Morgan Healthcare Conference is held in San Francisco Rowan DunneJanuary 17, 2025
Medical and Pharmaceutical South Korean researchers come up with novel treatment option for lung cancer Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases Joseph MortonJanuary 16, 2025
Medical and Pharmaceutical Phio Pharmaceuticals skyrockets on skin cancer drug trial success Shareholders are having a pretty stellar Monday with the immense gains Rowan DunneJanuary 13, 2025
Medical and Pharmaceutical ‘ORACLE’ lung cancer test helps predict survival with superior precision British researchers just published an extensive study on the tissue biopsy in Nature Cancer Rowan DunneJanuary 13, 2025
Medical and Pharmaceutical Sana Biotechnology could offer relief to diabetes type 1 sufferers in the future The study showed that Sana's hypoimmune (HIP) modified pancreatic islet cells could successfully evade the patient's immune system Joseph MortonJanuary 9, 2025
Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
Medical and Pharmaceutical Hoth Therapeutics up over 218% on dermatology breakthrough for cancer patients The biopharma operator's 'HT-001" drug was highly successful in alleviating skin issues caused by a cancer treatment Rowan DunneJanuary 7, 2025
Medical and Pharmaceutical Roche secures rights to Chinese biotech company’s small cell lung cancer drug Innovent Biologics will receive up to US$1 billion in milestone payments and royalties Rowan DunneJanuary 3, 2025